BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 11142486)

  • 1. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
    Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
    Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors.
    Pape H; Laws HJ; Burdach S; van Kaik B; Glag M; Gripp S; Wittkamp M; Jürgens H; Göbel U; Schmitt G
    Strahlenther Onkol; 1999 Oct; 175(10):484-7. PubMed ID: 10554642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
    Meyers PA; Krailo MD; Ladanyi M; Chan KW; Sailer SL; Dickman PS; Baker DL; Davis JH; Gerbing RB; Grovas A; Herzog CE; Lindsley KL; Liu-Mares W; Nachman JB; Sieger L; Wadman J; Gorlick RG
    J Clin Oncol; 2001 Jun; 19(11):2812-20. PubMed ID: 11387352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
    Burdach S; Jürgens H; Peters C; Nürnberger W; Mauz-Körholz C; Körholz D; Paulussen M; Pape H; Dilloo D; Koscielniak E
    J Clin Oncol; 1993 Aug; 11(8):1482-8. PubMed ID: 8101562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
    Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H
    J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report.
    Laws HJ; Burdach S; van Kaick B; Engel B; Dirksen U; Körholz D; Pape H; Kahn T; Merck H; Schmitz M; Heyll A; Dockhorn-Dworniczak B; Jürgens H; Göbel U
    Strahlenther Onkol; 1999 Oct; 175(10):488-94. PubMed ID: 10554643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.
    Paulussen M; Ahrens S; Burdach S; Craft A; Dockhorn-Dworniczak B; Dunst J; Fröhlich B; Winkelmann W; Zoubek A; Jürgens H
    Ann Oncol; 1998 Mar; 9(3):275-81. PubMed ID: 9602261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
    Tanaka K; Matsunobu T; Sakamoto A; Matsuda S; Iwamoto Y
    J Orthop Sci; 2002; 7(4):477-82. PubMed ID: 12181663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
    Laurence V; Pierga JY; Barthier S; Babinet A; Alapetite C; Palangié T; de Pinieux G; Anract P; Pouillart P
    Am J Clin Oncol; 2005 Jun; 28(3):301-9. PubMed ID: 15923805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS].
    Fröhlich B; Ahrens S; Burdach S; Klingebiel T; Ladenstein R; Paulussen M; Zoubek A; Jürgens H
    Klin Padiatr; 1999; 211(4):284-90. PubMed ID: 10472563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
    Laws HJ; van Kaick B; Pape H; Paulussen M; Göbel U
    Onkologie; 2003 Dec; 26(6):573-7. PubMed ID: 14709933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors.
    Hawkins D; Barnett T; Bensinger W; Gooley T; Sanders J
    Med Pediatr Oncol; 2000 May; 34(5):328-37. PubMed ID: 10797354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
    Ozkaynak MF; Matthay K; Cairo M; Harris RE; Feig S; Reynolds CP; Buckley J; Villablanca JG; Seeger RC
    J Clin Oncol; 1998 Mar; 16(3):937-44. PubMed ID: 9508176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
    Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
    Berglund A; Enblad G; Carlson K; Glimelius B; Hagberg H
    Eur J Haematol; 2000 Jul; 65(1):17-22. PubMed ID: 10914935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.